Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.

MetS was associated with increased risk of breast cancer mortality, especially among post-menopausal women. Further studies with larger sample sizes are needed to definitively determine the extent to which these associations vary by breast cancer subtype.